Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data

dc.contributor.authorDíaz, Natalia A
dc.contributor.authorde Miguel, Rosa
dc.contributor.authorAgüero, Fernando
dc.contributor.authorSued, Omar
dc.contributor.authorArribas, José R
dc.contributor.authorAmbriosioni, Juan
dc.contributor.authorHospital Clinic COVID-19 in HIV Investigators
dc.date.accessioned2024-05-23T23:49:02Z
dc.date.available2024-05-23T23:49:02Z
dc.date.issued2021-08
dc.descriptionFil: Díaz NA. Infectious Diseases Service, Hospital Cuenca Alta, Cañuelas; Argentinaes_ES
dc.description.abstractThe HIV pandemic has led to close to 40 million people living with HIV (PLWH) worldwide. To date, SARS-CoV2 has affected > 220 million people, and unprecedented global efforts have resulted in almost 6000 million doses of SARS-CoV2 vaccines being administered. Although several specific COVID-19 antiviral and anti-inflammatory treatments and SARS-CoV2 vaccines have been approved, the data available to support their use in specific populations such as PLWH remain limited. PLWH includes a range of individuals from practically unaffected immunity to severely immunocompromised individuals, and preventive and therapeutic interventions should be tailored for these subgroups . However, in most randomized clinical trials regarding antivirals, immunomodulators and vaccines for COVID-19, PLWH have been excluded or only enrolled in small numbers leading to a paucity of data. We briefly discuss the current evidence for prevention and treatment of COVID-19 in PLWH and identify key areas where more information is required.es_ES
dc.formatapplication/pdfes_ES
dc.identifier.doihttps://doi.org/10.1007/s40121-021-00547-y
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/1301
dc.languageENGes_ES
dc.provenancePublishedes_ES
dc.relation.ispartofseriesInfectious Diseases and Therapy;2022 Feb;11(1):1-13.
dc.rightsopenAccesses_ES
dc.subjectCOVID-19es_ES
dc.subjectVIHes_ES
dc.subjectInfecciones por VIHes_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectVacunas contra la COVID-19es_ES
dc.subjectTerapéuticaes_ES
dc.titlePrevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Dataes_ES
dc.typeArticuloes_ES

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.1007s40121-021-00547-y.pdf
Size:
531.1 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: